Tickblaze Partners with SnapTrade to Expand Into Equities and Crypto with Top Brokerage Integrations
OTTAWA, Ontario–(BUSINESS WIRE)–#activetrading—Tickblaze, the hybrid trading platform known for its award-winning discretionary and algorithmic... Read more.
Avidia Bancorp, Inc. Announces Subscription Offering Results
HUDSON, Mass.–(BUSINESS WIRE)–Avidia Bancorp, Inc. (the “Company”), the proposed holding company of Avidia Bank, announced today the results of the... Read more.
Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD
JIANGSU, China & HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#EyeSol–Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”),... Read more.
Endava Strengthens Executive Team
LONDON–(BUSINESS WIRE)–Endava plc (NYSE: DAVA), a leading next-generation technology services provider, today announces changes to its executive team.... Read more.
Trinity Industries, Inc. Announces Dual Listing on NYSE Texas
DALLAS–(BUSINESS WIRE)–Trinity Industries, Inc. (NYSE: TRN) (“Trinity”) announced today the dual listing of its common stock on NYSE Texas, the new,... Read more.
Bumo Secures $10 Million in Seed Funding to Modernize Child Care
LOS ANGELES–(BUSINESS WIRE)–Bumo, the leading on-demand child care marketplace, announced it has raised $10 million in seed funding. The round was led... Read more.
MEMX Appoints Ishaan Acharya as Chief Financial Officer
Acharya will oversee financial strategy designed to further capitalize on exchange operator’s rapid success NEW YORK–(BUSINESS WIRE)–MEMX, a technology-driven... Read more.
BostonGene Announces Collaboration with SWOG Cancer Research Network to Drive Personalized Approaches
BostonGene’s AI-powered multiomics platform will enable biomarker-driven treatment selection, advancing precision medicine and accelerating therapeutic development... Read more.
Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
– Zodasiran targets ANGPLT3, an emerging therapeutic target to treat HoFH and other dyslipidemias – YOSEMITE Phase 3 study further enhances Arrowhead’s... Read more.
Armaments Research Company (ARC) Awarded Task Order with Army DEVCOM to Transform Small Unit Resupply in Contested Environments
WASHINGTON–(BUSINESS WIRE)–Armaments Research Company (ARC) has been awarded a follow-on SBIR Phase III task order to transform small unit resupply (SUR)... Read more.